NovoCure Limited
-
Ticker
NVCR
-
Industry
Medical Laboratories & Research More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Portsmouth, New Hampshire
Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma.
REPORT RATINGS
4.8 / 5.0 (166)
NovoCure Limited reports have an aggregate usefulness score of 4.8 based on 166 reviews.
NovoCure Limited
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
View 2023 Corporate Responsibility Report
Older/Archived Annual Reports